Resuming anticoagulation in patients with atrial fibrillation experiencing intracranial hemorrhage

Globally, 32% to 70% patients with atrial fibrillation (AF) are prescribed oral anticoagulants (OACs) with warfarin for stroke prevention. However, patients with AF on OACs may experience intracranial hemorrhage (ICH), which presents a treatment dilemma. We therefore investigated whether resuming OA...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Victor Chien-Chia, Huang, Yi-Chun, Chen, Shao-Wei, Liu, Chi-Hung, Chang, Chun-Wei, Chen, Ching-Chang, Chang, Shang-Hung, Lin, Ming-Shyan, Lee, Tsong-Hai, Chen, Mien-Cheng, Hsieh, I-Chang, Chu, Pao-Hsien, Lin, Yu-Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
3400
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8360426/
https://www.ncbi.nlm.nih.gov/pubmed/34397946
http://dx.doi.org/10.1097/MD.0000000000026945

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8360426/
https://www.ncbi.nlm.nih.gov/pubmed/34397946
http://dx.doi.org/10.1097/MD.0000000000026945

Ejemplares similares